Photo: investing.com
Thermo Fisher Scientific Surpasses Q3 Expectations with 5% Revenue Growth
Thermo Fisher Scientific exceeded Q3 expectations with a 5% revenue growth, reporting adjusted Earnings per share of $5.79, which boosted its stock by 1.4%.
- For the quarter ended September 27, 2025, Thermo Fisher Scientific reported adjusted Earnings per share of $5.79, surpassing the analyst estimate of $5.50 by $0.29.
- Thermo Fisher Scientific achieved a revenue growth of 5%, totaling $11.12 billion, which exceeded the consensus estimate of $10.91 billion.
- Following the positive earnings report, shares of Thermo Fisher Scientific rose by 1.4%, reflecting investor confidence in the companys performance.
Por Qué Es Relevante
This strong performance from Thermo Fisher Scientific highlights the companys resilience in the scientific equipment sector, indicating robust demand for their products and services. Positive earnings can also signal to investors the potential for continued growth and stability in a fluctuating market.